NHE1 being the target of TESC in AML. HMA treatment completely abolished the growth inhibitory effects (A) and intracellular acidification (B) of TESC knockdown in MOLM-13 (Ai, Bi) and MV4-11 (Aii, Bii). n.s., no significant difference as defined by P > .05.